Trever Grant Bivona
University of California, San Francisco · 364 works · 21,758 citations · h-index 68
Top works
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations
- Ras signalling on the endoplasmic reticulum and the Golgi
- Understanding and targeting resistance mechanisms in NSCLC
- Phospholipase Cγ activates Ras on the Golgi apparatus by means of RasGRP1
- Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
- PKC Regulates a Farnesyl-Electrostatic Switch on K-Ras that Promotes its Association with Bcl-Xl on Mitochondria and Induces Apoptosis
- Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
- Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
- Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial
- Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
- Genetics and biomarkers in personalisation of lung cancer treatment
- RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer
- RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
- Membranes as messengers in T cell adhesion signaling
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas